Stockreport

Nasdaq's Listing and Hearing Review Council Stays Panel Determination Requiring Jaguar Health's Compliance with the Bid Price Requirement by December 23, 2020

Jaguar Health, Inc.  (JAGX) 
US:NASDAQ Investor Relations: jaguarhealth.gcs-web.com/investor-overview
PDF The Nasdaq Listing Council, on its own motion, will consider if the Company should have been granted a longer period within which to evidence compliance with the $1.00 p [Read more]